“vaccines” Archives

in
Entry Author Date Location
Roundup: S3 Ventures, TMCx, George Peoples, Disruptors in Houston 08/25/16 Texas
FluGen Starts Clinical Trial for Universal Flu Vaccine 07/27/16 Wisconsin
The Outbreaks Are Here, Where’s Our Response Plan? 07/25/16 Seattle
The Xconversation: Vaccine Developer Meets Energy Innovator, Part II 03/30/16 Seattle
The Xconversation: Vaccine Developer Meets Energy Innovator, Part I 03/29/16 Seattle
Former Gates Foundation Lawyer Tapped As WARF’s New Managing Director 03/24/16 Wisconsin
Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall 03/07/16 Boston
With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz 10/22/15 Boston
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall 10/19/15 Boston
Genocea Climbs on Follow-Up Data for Herpes Vaccine 10/07/15 Boston
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals 05/13/15 Boston
Big Apple Biotech “Bootstraps” Forward at NewYorkBio Meeting 05/05/15 New York
Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans 02/09/15 Boston
More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal 01/13/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software 12/16/14 New York
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines 03/10/14 Seattle
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
Page 2 of 11 « previous page · next page »

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.